Article
Performance Characteristics of a Real-Time Polymerase Chain Reaction Assay for the Detection of Epidermal Growth Factor Receptor (EGFR) Mutations in Plasma Samples of Non-Small Cell Lung Cancer (NSCLC) Patients.
Molecular diagnosis & therapy - 1 Aug 2020
O'Donnell Patrick, May Theresa, DeMartin Kelli, Ferguson Jane, Halait Harkanwal, Wei Wen, Yu Karen, Scudder Sid
Abstract excerpt
BACKGROUND: Circulating free DNA in plasma is an alternative source of tumor-derived DNA that can be a surrogate for tissue epidermal growth factor receptor (EGFR) testing. OBJECTIVE: We evaluated the analytical performance of the cobas® EGFR Mutation Test v2 (cobas test), a real-time polymerase chain reaction assay designed to detect defined EGFR gene mutations in plasma from patients with advanced non-small...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
